Loading...
SomnoMed Limited
SOM.AX•ASX
Healthcare
Medical - Devices
A$0.78
A$-0.04(-4.91%)
SomnoMed Limited (SOM.AX) Financial Performance & Income Statement Overview
Review SomnoMed Limited’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
9.61%
↑ 9.61%
Operating Income Growth
-104.52%
↓ 104.52%
Net Income Growth
-53.04%
↓ 53.04%
Operating Cash Flow Growth
-63.21%
↓ 63.21%
Operating Margin
-0.68%
↓ 0.68%
Gross Margin
57.15%
↑ 57.15%
Net Profit Margin
-5.99%
↓ 5.99%
ROE
-12.98%
↓ 12.98%
ROIC
-1.31%
↓ 1.31%
SomnoMed Limited (SOM.AX) Income Statement & Financial Overview
Review SomnoMed Limited's (SOM.AX) income statement with detailed quarterly and annual figures.
| Metric | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 |
|---|---|---|---|---|
| Revenue | $53.71M | $46.54M | $45.11M | $43.66M |
| Cost of Revenue | $20.61M | $22.34M | $20.48M | $20.18M |
| Gross Profit | $33.09M | $24.19M | $24.64M | $23.48M |
| Gross Profit Ratio | $0.62 | $0.52 | $0.55 | $0.54 |
| R&D Expenses | $707727.00 | $461045.00 | $581438.00 | $346812.00 |
| SG&A Expenses | $28.75M | $27.98M | $28.58M | $25.13M |
| Operating Expenses | $29.45M | $28.44M | $29.16M | $25.48M |
| Total Costs & Expenses | $50.07M | $50.78M | $49.63M | $45.65M |
| Interest Income | $11009.00 | $23716.00 | $6352.00 | $1563.00 |
| Interest Expense | $128241.00 | $1.67M | $1.49M | $2.12M |
| Depreciation & Amortization | $1.65M | $2.87M | $2.90M | $2.76M |
| EBITDA | $3.07M | -$1.63M | -$1.15M | $759560.00 |
| EBITDA Ratio | $0.06 | -$0.03 | -$0.03 | $0.02 |
| Operating Income | $3.64M | -$4.32M | -$4.52M | -$2.00M |
| Operating Income Ratio | $0.07 | -$0.09 | -$0.10 | -$0.05 |
| Other Income/Expenses (Net) | -$2.13M | -$1.40M | -$3.22M | -$2.17M |
| Income Before Tax | $1.51M | -$5.72M | -$5.55M | -$4.16M |
| Income Before Tax Ratio | $0.03 | -$0.12 | -$0.12 | -$0.10 |
| Income Tax Expense | $1.61M | $170068.00 | $801032.00 | -$1554.00 |
| Net Income | -$105538.00 | -$5.89M | -$6.35M | -$4.25M |
| Net Income Ratio | -$0.002 | -$0.13 | -$0.14 | -$0.10 |
| EPS | -$0.05 | -$0.05 | -$0.05 | -$0.04 |
| Diluted EPS | -$0.05 | -$0.05 | -$0.05 | -$0.04 |
| Weighted Avg Shares Outstanding | $2.11M | $120.76M | $120.79M | $111.83M |
| Weighted Avg Shares Outstanding (Diluted) | $2.11M | $120.76M | $120.79M | $111.83M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan